Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
48.37
+1.81 (3.89%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $3.08 billion as of October 23, 2024. Its market cap has increased by 300.40% in one year.
Market Cap
3.08B
Enterprise Value
2.47B
1-Year Change
300.40%
Ranking
Category
Stock Price
$48.37
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $3.08B, an increase of 269.55%. That is a compound annual growth rate of 36.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 2.99B | 111.44% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -58.03% |
| Dec 31, 2021 | 3.26B | 18.36% |
| Dec 31, 2020 | 2.76B | 230.32% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 3.11B |
| MoonLake Immunotherapeutics | 3.08B |
| PTC Therapeutics | 3.01B |
| Bausch Health Companies | 3.00B |
| Astrana Health | 2.97B |
| LivaNova | 2.91B |
| Verona Pharma | 2.81B |
| Ardent Health Partners | 2.79B |